Stock data
Astellas Pharma$10.07
4503 
0.35% • 24 H
0.35% • 24 HDividend Yield:3.5%
Global Rank#938
Market Cap$18.33B
YTD Performance-7.84%
P/E0.19
Revenue$9.67B
Change 7d3.77%
SP500 BenchmarkUnderperform
Country🇯🇵 Japan
P/S1.90
Earnings$628.57M
Dividend Yield:3.5%
Main Sector
Healthcare
Astellas Pharma (4503) Cash on Hand
4503 Cash on Hand in 2022: $2.53B
According to Astellas Pharma latest financial reports the cash on hand of 4503 is $2.53B, an increase of 17.59% to 2022. At the end of 2022 company had $2.15B cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
4503 Cash on Hand History from 2019 to 2023
-
Value:-
4503 Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $2.53B | 17.59% |
| 2022 | $2.15B | 1.69% |
| 2021 | $2.11B | 1.17% |
| 2020 | $2.09B | 4.52% |
| 2019 | $2.00B | - |
View the Top Cash on Hand Companies 
